Scientific Domain of This Journal     (Go to your account to modify this domain)
This report is created for the scientific domain defined by:
Publications:
Bruna J, Simó M, Velasco R: Leptomeningeal metastases. Curr Treat Options Neurol; 2012 Aug;14(4):402-15 . PMID: 22736147.
Fulltext service  |  More from the authors  |  Email 35078jbe@ comb.cat  |  Citation export
Keywords:
(no keyword)

Table of Contents


Note: blue texts are hyperlinks to webpages outside this document, and dashed italic texts are links within this document.




List 1 Top 20 Articles, in the Domain of Article 22736147, Since its Publication (2012)

► What is this list? Read the explanation.
► Note: when none of the articles in the list is relevant to your topic, this means there haven't been new publications on your topic in this time-frame.
► Note: orange text shows articles published within the past 6 months, and green text shows articles published within the past 18 months.

1. Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis.
Le Rhun E, Massin F, Tu Q, Bonneterre J, Bittencourt Mde C, Faure GC.
BMC Clin Pathol; 2012;12:21.

Fulltext service  |  More from the authors  |  Email E-lerhun@ o-lambret.fr  |  Citation export

2. 'Steroids' associated with 'Cancer With Leptomeningeal Spread': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; Steroid;CancerWithLeptomeningeal:705831528. ISSN: 2331-5717. 2014/4/29.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

3. Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.
Le Rhun E, Taillibert S, Chamberlain MC.
Surg Neurol Int; 2013;4(Suppl 4):S265-88.

4. Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids.
Bougel S, Lhermitte B, Gallagher G, de Flaugergues JC, Janzer RC, Benhattar J.
Clin Cancer Res; 2013 Apr 15;19(8):2216-23.

5. 'Amino Acids, Peptides, or Proteins' associated with 'Cancer With Leptomeningeal Spread': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; AminoAcidPeptide;CancerWithLeptomeningeal:705767566. ISSN: 2331-5717. 2014/4/27.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

6. Leptomeningeal metastases in breast cancer.
Scott BJ, Kesari S.
Am J Cancer Res; 2013;3(2):117-26.

7. Leptomeningeal metastases.
Bruna J, Simó M, Velasco R.
Curr Treat Options Neurol; 2012 Aug;14(4):402-15.
Fulltext service  |  More from the authors  |  Email 35078jbe@ comb.cat  |  Citation export

8. Prolonged survival of patients with breast cancer-related leptomeningeal metastases.
Le Rhun E, Taillibert S, Zairi F, Pannier D, Boulanger T, Andre C, Cazin JL, Dubois F, Bonneterre J, Chamberlain MC.
Anticancer Res; 2013 May;33(5):2057-63.
Fulltext service  |  More from the authors  |  Email E-lerhun@ o-lambret.fr  |  Citation export

9. Treatment of leptomeningeal spread of NSCLC: a continuing challenge.
Nagpal S, Riess J, Wakelee H.
Curr Treat Options Oncol; 2012 Dec;13(4):491-504.
Fulltext service  |  More from the authors  |  Email snagpal@ stanford.edu  |  Citation export

10. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
Chamberlain MC.
J Neurooncol; 2012 Aug;109(1):143-8.
Fulltext service  |  More from the author  |  Email chambemc@ u.washington.edu  |  Citation export

11. [Clinical features and prognostic factors in patients with leptomeningeal metastases].
Li N, Yang BY, Li JL, Zhu JQ, Zou BH, Wang YF, Yu L, Yao XY.
Zhonghua Zhong Liu Za Zhi; 2013 Nov;35(11):867-70.
Fulltext service  |  More from the authors  |  Email yby6599.yong@ vip.sina.com  |  Citation export

12. High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases--one with a remarkable thoracic response as well.
Kuiper JL, Smit EF.
Lung Cancer; 2013 Apr;80(1):102-5.
Fulltext service  |  More from the authors  |  Email jl.kuiper@ vumc.nl  |  Citation export

13. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY, Chung WK, Oh IJ.
Clin Neurol Neurosurg; 2014 Apr;119:80-3.
Fulltext service  |  More from the authors  |  Email jung-ty@ chonnam.ac.kr%3AD%3AL%3ADepartment  |  Citation export

14. Intrathecal liposomal cytarabine and leptomeningeal medulloblastoma relapse: a valuable therapeutic option.
Mastronuzzi A, Del Bufalo F, Iacono A, Secco DE, Serra A, Colafati GS, DE Ioris MA, Corsetti T.
Anticancer Res; 2013 Aug;33(8):3515-8.
Fulltext service  |  More from the authors  |  Email angela.mastronuzzi@ opbg.netSiewert  |  Citation export

15. [Treatment of the leptomeningeal metastases related to solid tumors].
Le Rhun E, Zairi F.
Bull Cancer; 2013 Jul-Aug;100(7-8):765-74.
Fulltext service  |  More from the authors  |  Email emilie.lerhun@ chru-lille.fr  |  Citation export

16. Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.
Fusco JP, Castañón E, Carranza OE, Zubiri L, Martín P, Espinós J, Rodríguez J, Santisteban M, Aramendía JM, Gil-Bazo I.
J Neurooncol; 2013 Dec;115(3):429-35.

17. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
Jo JC, Kang MJ, Kim JE, Ahn JH, Jung KH, Gong G, Kim HH, Ahn SD, Kim SS, Son BH, Ahn SH, Kim SB.
Cancer Chemother Pharmacol; 2013 Jul;72(1):201-7.

18. A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.
Le Rhun E, Taillibert S, Zairi F, Kotecki N, Devos P, Mailliez A, Servent V, Vanlemmens L, Vennin P, Boulanger T, Baranzelli MC, André C, Marliot G, Cazin JL, Dubois F, Assaker R, Bonneterre J, Chamberlain MC.
J Neurooncol; 2013 May;113(1):83-92.
Fulltext service  |  More from the authors  |  Email emilie.lerhun@ chru-lille.fr  |  Citation export

19. Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.
Kumthekar P, Grimm SA, Avram MJ, Kaklamani V, Helenowski I, Rademaker A, Cianfrocca M, Gradishar W, Patel J, Mulcahy M, McCarthy K, Raizer JJ.
J Neurooncol; 2013 Apr;112(2):247-55.

20. Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
Le Rhun E, Taillibert S, Devos P, Zairi F, Turpin A, Rodrigues I, Cazin JL, Pierret MF, André C, Dubois F, Bonneterre J, Chamberlain MC.
Anticancer Drugs; 2013 Nov;24(10):1093-7.







List 2 Top 20 Articles, in the Domain of Article 22736147, in the Past 1 Month

► Note: when none of the articles in the list is relevant to your topic, this means there haven't been new publications on your topic in this time-frame.

1. 'Steroids' associated with 'Cancer With Leptomeningeal Spread': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; Steroid;CancerWithLeptomeningeal:705831528. ISSN: 2331-5717. 2014/4/29.

Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

2. 'Amino Acids, Peptides, or Proteins' associated with 'Cancer With Leptomeningeal Spread': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; AminoAcidPeptide;CancerWithLeptomeningeal:705767566. ISSN: 2331-5717. 2014/4/27.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

3. 'Steroids' associated with 'Leptomeningeal Cancer': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; Steroid;LeptomeningealCancer:705816824. ISSN: 2331-5717. 2014/4/28.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

4. 'Amino Acids, Peptides, or Proteins' associated with 'Leptomeningeal Cancer': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; AminoAcidPeptide;LeptomeningealCancer:705742774. ISSN: 2331-5717. 2014/4/26.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

5. Anticancer therapy for breast cancer patients with skin metastases refractory to conventional treatments.
Varol U, Yildiz I, Alacacioglu A, Uslu R.
Asian Pac J Cancer Prev; 2014;15(4):1885-7.
Fulltext service  |  More from the authors  |  Email varolumut@ yahoo.com  |  Citation export

6. The value of radiotherapy in breast cancer patients with isolated ipsilateral supraclavicular lymph node metastasis without distant metastases at diagnosis: a retrospective analysis of Chinese patients.
Wu SG, Sun JY, Zhou J, Li FY, Lin Q, Lin HX, He ZY.
Onco Targets Ther; 2014;7:281-8.

7. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY, Chung WK, Oh IJ.
Clin Neurol Neurosurg; 2014 Apr;119:80-3.
Fulltext service  |  More from the authors  |  Email jung-ty@ chonnam.ac.kr%3AD%3AL%3ADepartment  |  Citation export

8. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Tran HC, Gardner S, Weiner HL, Liebes LF, Finlay JL.
J Oncol Pharm Pract; 2014 Jun;20(3):229-32.

9. Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era.
Riess JW, Nagpal S, Iv M, Zeineh M, Gubens MA, Ramchandran K, Neal JW, Wakelee HA.
Clin Lung Cancer; 2014 May;15(3):202-6.
Fulltext service  |  More from the authors  |  Email jonathan.riess@ ucdmc.ucdavis.edu%3AD%3AL%3ADivision  |  Citation export

10. [Surgical treatment of metastases and its impact on prognosis in patients with metastatic colorectal carcinoma].
Sevc(íková K, Ušáková V, Bartošová Z, Sabol M, Ondrušová M, Ondruš D, Spánik S.
Klin Onkol; 2014;27(1):38-44.

11. Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases.
Nieder C, Marienhagen K, Dalhaug A, Aandahl G, Haukland E, Pawinski A.
Med Oncol; 2014 Apr;31(4):927.
Fulltext service  |  More from the authors  |  Email carsten.nieder@ nlsh.no  |  Citation export

12. Brain metastases.
Gállego Pérez-Larraya J, Hildebrand J.
Handb Clin Neurol; 2014;121:1143-57.
Fulltext service  |  More from the authors  |  Email jgallego@ unav.es%3AD%3AL%3AFédération  |  Citation export

13. Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center.
Dalia S, Forsyth P, Chavez J, Price S, Shah B, Bello C, Sokol L, Pan E, Sotomayor E, Lee JH, Fisher K, Jaglal M.
Int J Hematol; 2014 Apr;99(4):450-6.
Fulltext service  |  More from the authors  |  Email sdalia@ gmail.com  |  Citation export

14. Leptomeningeal gliomatosis with high levels of adenosine deaminase in the cerebrospinal fluid.
Nishihara H, Omoto M, Ogasawara J, Koga M, Kawai M, Kanda T.
Rinsho Shinkeigaku; 2014;54(4):308-12.

15. Predicting the presence of extracranial metastases in patients with brain metastases upon first diagnosis of cancer.
Rades D, Segedin B, Nagy V, Schild SE, Trang NT, Khoa MT.
Strahlenther Onkol; 2014 Apr;190(4):405-7.
Fulltext service  |  More from the authors  |  Email Rades.Dirk@ gmx.net  |  Citation export

16. Primary leptomeningeal melanocytosis presenting as chronic meningitis.
Honigberg MC, Papavassiliou E, Cohen YZ.
J Clin Neurosci; 2014 Jun;21(6):1056-8.
Fulltext service  |  More from the authors  |  Email Michael_Honigberg@ hms.harvard.edu%3AD%3AL%3ADivision  |  Citation export

17. Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary.
Janssen S, Glanzmann C, Huber G, Studer G.
Strahlenther Onkol; 2014 Apr;190(4):386-93.

18. Phase II trial of patupilone in patients with brain metastases from breast cancer.
Peereboom DM, Murphy C, Ahluwalia MS, Conlin A, Eichler A, Van Poznak C, Baar J, Elson P, Seidman AD.
Neuro Oncol; 2014 Apr;16(4):579-83.

19. [Impact of Time of Occurrence of Liver Metastases (Synchronous vs. Metachronous) on Early Postoperative Outcome and Long-Term Survival of Colorectal Cancer Patients].
Bova R, Kamphues C, Neuhaus P, Puhl G.
Zentralbl Chir; 2014 Apr;139(2):220-5.

20. Primary leptomeningeal melanoma.
Xie ZY, Hsieh KL, Tsang YM, Cheung WK, Hsieh CH.
J Clin Neurosci; 2014 Jun;21(6):1051-2.
Fulltext service  |  More from the authors  |  Email kevinh9396@ gmail.com%3AD%3AL%3ADepartment  |  Citation export







List 3 Top 21 Articles, in the Domain of Article 22736147, in the Past 3 Months

► Note: when none of the articles in the list is relevant to your topic, this means there haven't been new publications on your topic in this time-frame.

1. 'Steroids' associated with 'Cancer With Leptomeningeal Spread': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; Steroid;CancerWithLeptomeningeal:705831528. ISSN: 2331-5717. 2014/4/29.

Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

2. 'Amino Acids, Peptides, or Proteins' associated with 'Cancer With Leptomeningeal Spread': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; AminoAcidPeptide;CancerWithLeptomeningeal:705767566. ISSN: 2331-5717. 2014/4/27.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

3. 'Steroids' associated with 'Leptomeningeal Cancer': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; Steroid;LeptomeningealCancer:705816824. ISSN: 2331-5717. 2014/4/28.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

4. 'Amino Acids, Peptides, or Proteins' associated with 'Leptomeningeal Cancer': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; AminoAcidPeptide;LeptomeningealCancer:705742774. ISSN: 2331-5717. 2014/4/26.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

5. Anticancer therapy for breast cancer patients with skin metastases refractory to conventional treatments.
Varol U, Yildiz I, Alacacioglu A, Uslu R.
Asian Pac J Cancer Prev; 2014;15(4):1885-7.
Fulltext service  |  More from the authors  |  Email varolumut@ yahoo.com  |  Citation export

6. The value of radiotherapy in breast cancer patients with isolated ipsilateral supraclavicular lymph node metastasis without distant metastases at diagnosis: a retrospective analysis of Chinese patients.
Wu SG, Sun JY, Zhou J, Li FY, Lin Q, Lin HX, He ZY.
Onco Targets Ther; 2014;7:281-8.

7. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY, Chung WK, Oh IJ.
Clin Neurol Neurosurg; 2014 Apr;119:80-3.
Fulltext service  |  More from the authors  |  Email jung-ty@ chonnam.ac.kr%3AD%3AL%3ADepartment  |  Citation export

8. CSF CA 15-3 in breast cancer-related leptomeningeal metastases.
Le Rhun E, Kramar A, Salingue S, Girot M, Rodrigues I, Mailliez A, Zairi F, Bakhache E, Robin YM, Taillibert S, Dubois F, Bonneterre J, Chamberlain MC.
J Neurooncol; 2014 Mar;117(1):117-24.
Fulltext service  |  More from the authors  |  Email le_rhun@ yahoo.fr  |  Citation export

9. Diencephalic storms from leptomeningeal metastases and leukoencephalopathy: a rare and clinically important complication.
Soriano A, Gutgsell TL, Davis MP.
Am J Hosp Palliat Care; 2014 Feb;31(1):98-100.

10. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Tran HC, Gardner S, Weiner HL, Liebes LF, Finlay JL.
J Oncol Pharm Pract; 2014 Jun;20(3):229-32.

11. [A case of intracranial primary leptomeningeal lymphoma].
Kin K, Ono Y, Hisamatsu Y, Kuramoto S, Katsumata A, Yoshida H, Kawauchi M, Nakamura S.
No Shinkei Geka; 2014 Mar;42(3):233-9.

12. Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era.
Riess JW, Nagpal S, Iv M, Zeineh M, Gubens MA, Ramchandran K, Neal JW, Wakelee HA.
Clin Lung Cancer; 2014 May;15(3):202-6.
Fulltext service  |  More from the authors  |  Email jonathan.riess@ ucdmc.ucdavis.edu%3AD%3AL%3ADivision  |  Citation export

13. [Surgical treatment of metastases and its impact on prognosis in patients with metastatic colorectal carcinoma].
Sevc(íková K, Ušáková V, Bartošová Z, Sabol M, Ondrušová M, Ondruš D, Spánik S.
Klin Onkol; 2014;27(1):38-44.

14. Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases.
Nieder C, Marienhagen K, Dalhaug A, Aandahl G, Haukland E, Pawinski A.
Med Oncol; 2014 Apr;31(4):927.
Fulltext service  |  More from the authors  |  Email carsten.nieder@ nlsh.no  |  Citation export

15. Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.
Agarwala SS, Eggermont AM, O'Day S, Zager JS.
Cancer; 2014 Mar 15;120(6):781-9.

16. Brain metastases.
Gállego Pérez-Larraya J, Hildebrand J.
Handb Clin Neurol; 2014;121:1143-57.
Fulltext service  |  More from the authors  |  Email jgallego@ unav.es%3AD%3AL%3AFédération  |  Citation export

17. Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center.
Dalia S, Forsyth P, Chavez J, Price S, Shah B, Bello C, Sokol L, Pan E, Sotomayor E, Lee JH, Fisher K, Jaglal M.
Int J Hematol; 2014 Apr;99(4):450-6.
Fulltext service  |  More from the authors  |  Email sdalia@ gmail.com  |  Citation export

18. Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials.
Iacovelli R, Alesini D, Palazzo A, Trenta P, Santoni M, De Marchis L, Cascinu S, Naso G, Cortesi E.
Cancer Treat Rev; 2014 Mar;40(2):271-5.
Fulltext service  |  More from the authors  |  Email roberto.iacovelli@ alice.it  |  Citation export

19. Leptomeningeal gliomatosis with high levels of adenosine deaminase in the cerebrospinal fluid.
Nishihara H, Omoto M, Ogasawara J, Koga M, Kawai M, Kanda T.
Rinsho Shinkeigaku; 2014;54(4):308-12.

20. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
Gruber-Rouh T, Naguib NN, Eichler K, Ackermann H, Zangos S, Trojan J, Beeres M, Harth M, Schulz B, Nour-Eldin A NE, Vogl TJ.
Int J Cancer; 2014 Mar 1;134(5):1225-31.

21. Predicting the presence of extracranial metastases in patients with brain metastases upon first diagnosis of cancer.
Rades D, Segedin B, Nagy V, Schild SE, Trang NT, Khoa MT.
Strahlenther Onkol; 2014 Apr;190(4):405-7.
Fulltext service  |  More from the authors  |  Email Rades.Dirk@ gmx.net  |  Citation export







List 4 Top 21 Articles, in the Domain of Article 22736147, in the Past 0.5 Month

► Note: when none of the articles in the list is relevant to your topic, this means there haven't been new publications on your topic in this time-frame.

1. Anticancer therapy for breast cancer patients with skin metastases refractory to conventional treatments.
Varol U, Yildiz I, Alacacioglu A, Uslu R.
Asian Pac J Cancer Prev; 2014;15(4):1885-7.

Fulltext service  |  More from the authors  |  Email varolumut@ yahoo.com  |  Citation export

2. The value of radiotherapy in breast cancer patients with isolated ipsilateral supraclavicular lymph node metastasis without distant metastases at diagnosis: a retrospective analysis of Chinese patients.
Wu SG, Sun JY, Zhou J, Li FY, Lin Q, Lin HX, He ZY.
Onco Targets Ther; 2014;7:281-8.

3. Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities--single center experience.
Cabuk D, Basaran G, Teomete M, Dane F, Korkmaz T, Seber S, Telli F, Yumuk PF, Turhal S.
Asian Pac J Cancer Prev; 2014;15(1):117-22.
Fulltext service  |  More from the authors  |  Email devrimcabuk@ yahoo.com  |  Citation export

4. Management of a patient with metastatic colorectal cancer and liver metastases.
Saif MW.
Case Rep Oncol Med; 2014;2014:790192.

5. Importance of HER2 Work-Up and Treatment Even in Patients with Poor Performance Status: A Case Report.
Suner A, Buyukhatipoglu H, Balakan O, Kalender ME, Ulas T, Sevinc A, Camci C.
Case Rep Oncol Med; 2014;2014:731581.

6. Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial.
Rief H, Omlor G, Akbar M, Welzel T, Bruckner T, Rieken S, Haefner MF, Schlampp I, Gioules A, Habermehl D, von Nettelbladt F, Debus J.
BMC Cancer; 2014;14:67.
Fulltext service  |  More from the authors  |  Email harald.rief@ med.uni-heidelberg.de  |  Citation export

7. 'Steroids' associated with 'Ommaya Reservoir': Top Publications.
Cooper IF, Siadaty MS.
BioMedLib Review; Steroid;OmmayaReservoir:705928124. ISSN: 2331-5717. 2014/5/5.
Fulltext service  |  More from the authors  |  Email isabelle.cooper@ bmlsearch.com;  |  Citation export

8. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Tran HC, Gardner S, Weiner HL, Liebes LF, Finlay JL.
J Oncol Pharm Pract; 2014 Jun;20(3):229-32.

9. Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era.
Riess JW, Nagpal S, Iv M, Zeineh M, Gubens MA, Ramchandran K, Neal JW, Wakelee HA.
Clin Lung Cancer; 2014 May;15(3):202-6.
Fulltext service  |  More from the authors  |  Email jonathan.riess@ ucdmc.ucdavis.edu%3AD%3AL%3ADivision  |  Citation export

10. [Surgical treatment of metastases and its impact on prognosis in patients with metastatic colorectal carcinoma].
Sevc(íková K, Ušáková V, Bartošová Z, Sabol M, Ondrušová M, Ondruš D, Spánik S.
Klin Onkol; 2014;27(1):38-44.

11. Brain metastases.
Gállego Pérez-Larraya J, Hildebrand J.
Handb Clin Neurol; 2014;121:1143-57.
Fulltext service  |  More from the authors  |  Email jgallego@ unav.es%3AD%3AL%3AFédération  |  Citation export

12. Leptomeningeal gliomatosis with high levels of adenosine deaminase in the cerebrospinal fluid.
Nishihara H, Omoto M, Ogasawara J, Koga M, Kawai M, Kanda T.
Rinsho Shinkeigaku; 2014;54(4):308-12.

13. Primary leptomeningeal melanocytosis presenting as chronic meningitis.
Honigberg MC, Papavassiliou E, Cohen YZ.
J Clin Neurosci; 2014 Jun;21(6):1056-8.
Fulltext service  |  More from the authors  |  Email Michael_Honigberg@ hms.harvard.edu%3AD%3AL%3ADivision  |  Citation export

14. Primary leptomeningeal melanoma.
Xie ZY, Hsieh KL, Tsang YM, Cheung WK, Hsieh CH.
J Clin Neurosci; 2014 Jun;21(6):1051-2.
Fulltext service  |  More from the authors  |  Email kevinh9396@ gmail.com%3AD%3AL%3ADepartment  |  Citation export

15. The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre.
Ung L, Chua TC, Morris DL.
J Cancer Res Clin Oncol; 2014 Jun;140(6):1037-45.

16. Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case-control matched-pairs analysis.
Montalti R, Berardi G, Laurent S, Sebastiani S, Ferdinande L, Libbrecht LJ, Smeets P, Brescia A, Rogiers X, de Hemptinne B, Geboes K, Troisi RI.
Eur J Surg Oncol; 2014 May;40(5):536-44.
Fulltext service  |  More from the authors  |  Email roberto.troisi@ ugent.be  |  Citation export

17. A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients.
Evers JN, Schild SE, Segedin B, Nagy V, Khoa MT, Trang NT, Rades D.
Anticancer Res; 2014 May;34(5):2455-8.
Fulltext service  |  More from the authors  |  Email Rades.Dirk@ gmx.net  |  Citation export

18. Predictive value of optimal morphologic response to first-line chemotherapy in patients with colorectal liver metastases.
Yoshita H, Hosokawa A, Ueda A, Ando T, Kajiura S, Kato H, Kawabe H, Tomizawa G, Horikawa N, Yabuhita K, Note M, Sugiyama T.
Digestion; 2014;89(1):43-8.

19. COX-2 Drives Metastatic Breast Cells from Brain Lesions into the Cerebrospinal Fluid and Systemic Circulation.
Allen JE, Patel AS, Prabhu VV, Dicker DT, Sheehan JM, Glantz MJ, El-Deiry WS.
Cancer Res; 2014 May 1;74(9):2385-90.

20. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
Boye K, Del Prever AB, Eriksson M, Saeter G, Tienghi A, Lindholm P, Fagioli F, Skjeldal S, Ferrari S, Hall KS.
Pediatr Blood Cancer; 2014 May;61(5):840-5.

21. Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.
de Mestier L, Neuzillet C, Pozet A, Desot E, Deguelte-Lardière S, Volet J, Karoui M, Kianmanesh R, Bonnetain F, Bouché O.
Eur J Surg Oncol; 2014 Jun;40(6):685-91.
Fulltext service  |  More from the authors  |  Email louisdemestier@ hotmail.com%3AD%3AL%3ADepartment  |  Citation export







List 5 Articles Citing the Publication 22736147

► What is this list? Read the explanation.
► Note: this list may not be exhaustive. Some of the cross-citation data is owned by publishers which we may not have access.
► Note: orange text shows articles published within the past 6 months, and green text shows articles published within the past 18 months.

NOTE: at this time we did not find any citations; this may change in future. However some citation information is proprietary to which we may not have access.







Manage your subscription


Please use the "Email administration" section of the email you received to manage your subscription. For security reasons we have de-activated some of the links and actions here.



Subscribe | Unsubscribe | Update profile/email address | Contact BioMedUpdater | Privacy policy




Please do not reply to this message to opt out; click Unsubscribe.

You received this email because you have requested it. You are on the mailing list as 35078jbe@comb.cat .
If you didn't request this email yourself, a friend forwarded it to you. Start receiving your own copies of the free WiPiMD journal.

To ensure delivery to your inbox, please add mail@BioMedLibMail.com to your address book.

This is a free service of BioMedUpdater LLC.
Need to contact us?
http://biomedupdater.com/?flnm2=contactinfo.html
custserv@bmljournal.com
BioMedUpdater LLC, PO Box 4786, 2150 Wise Street, Charlottesville, VA 22905-9998.

Disclaimer: BioMedUpdater publishes citations to peer-reviewed publications. These citations should not be considered as either individual advice or as a substitute for medical and other professional services.




BioMedUpdater has a strict NO SPAM policy.
BioMedUpdater is always looking out for your Internet safety.
Note: when you unsubscribe, if you used multiple emails to sign up, you must opt out of all of them so the mailings will be fully discontinued.
Disclaimer: The CAN-SPAM Act of 2003 (Controlling the Assault of Non-Solicited Pornography and Marketing Act) establishes requirements for those who send commercial email, spells out penalties for spammers and companies whose products are advertised in spam if they violate the law, and gives consumers the right to ask mailers to stop spamming them. The above mail is in accordance with the CAN-SPAM act of 2003. You can opt out by clicking the link "Remove" and we will ensure that you will not receive any additional mails from BioMedUpdater.com

Copyright © 2014 by BioMedUpdater, LLC. All rights reserved.
BioMedUpdater, the WiPiMD, and the BioMedLib logo are trade or service marks of BioMedUpdater, LLC.

If you have general questions or comments, contact us at custserv@bmljournal.com
BioMedUpdater LLC, PO Box 4786, 2150 Wise Street, Charlottesville, VA 22905-9998.

[CommMgrTok:ICD40528TWjN0sIouBkw5iq]